Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Tianjin Pharmaceutical Da Ren Tang Group has announced the completion of its disposal of a 13% equity interest in Tianjin TSKF Pharmaceutical Co., Ltd. to Haleon China Co., Ltd. This strategic move, classified as an interested person transaction, reflects the company’s efforts to optimize its investment portfolio and potentially enhance shareholder value.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue